Neuropace (NPCE) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Neuropace in October 2026.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Neuropace (NPCE) Stock Forecast
Analyst price target, next 12 months
$18.45
+45.3% vs today's $12.70
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Neuropace have a consensus 12-month target of $18.45, above the current price of $12.70.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 18 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying NeuroPace's stock with a target price of $18.45, indicating growth potential.
Financial Health
NeuroPace is showing strong revenue and profit margins, indicating solid financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
